Piper Jaffray Starts AcelRx Pharmaceuticals (ACRX) at Overweight
Tweet
Share
E-mailGet Alerts ACRX Hot Sheet
Price: $0.86 --0%
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Piper Jaffray initiates coverage on AcelRx Pharmaceuticals (NASDAQ: ACRX) with an Overweight. PT $7.
For more ratings news on AcelRx Pharmaceuticals click here and for the rating history of AcelRx Pharmaceuticals click here.
Shares of AcelRx Pharmaceuticals closed at $3.33 yesterday.
For more ratings news on AcelRx Pharmaceuticals click here and for the rating history of AcelRx Pharmaceuticals click here.
Shares of AcelRx Pharmaceuticals closed at $3.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
- Chardan Starts Odysight.AI Inc. (ODYS) at Buy
- Goldman Sachs Starts Luxshare Precision (2475:HK) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
